11
May
Cat Allergy Vaccine Hypocat. This work was a key. This treatment is a stark contrast to decongestant sprays or daily allergy pills which require consistent use to effectively prevent allergy. An innovative approach was tested to treat cat allergy in humans by vaccinating cats with Fel-CuMV HypoCat TM a vaccine against the major cat allergen Fel d 1 based on virus-like particles derived from cucumber mosaic virus CuMV-VLPs. The researchers said all 54 cats injected with their HypoCat vaccine went on to produce the antibodies that could destroy the protein causing discomfort for so many of us.
But the vaccine isnt for them. After the initial vaccination cats will only have to be vaccinated roughly every six months to a year to maintain the effects. Fel-CuMV TT to be marketed as HypoCat vaccine by Swiss company HypoPet was developed through a collaboration between researchers at the Latvian Biomedical Research and Study Centre in Riga. The science behind the Cat allergy vaccine is simple enough to understand. Researchers in Switzerland are investigating whether a vaccine called HypoCat can be administered to felines to reduce their allergen load. Scientists have spent close to a.
This vaccine uses a virus-like particle to provoke the cats immune system to immunize it against its own allergenic protein.
Upon vaccination cats develop neutralizing antibodies against the allergen Fel d 1 which reduces the level of reactive allergen thus lowering the symptoms. HypoCat is a vaccine currently being developed that would be administered to cats keeping them from producing a common allergen that affects many people. A team of scientists from the Swiss firm HypoPet AG has developed a vaccine to combat the feline-produced protein Fel d 1 to which 10 of humans are allergic according to their press release. According to a HydroPet news release the vaccine called HypoCat has already shown success in neutralizing the allergen in cats without overt toxicity. But the vaccine isnt for them. Researchers in Switzerland are investigating whether a vaccine called HypoCat can be administered to felines to reduce their allergen load.